How do I calculate the dialysate composition, hemodialysis duration, and ultrafiltration volume for a patient initiating hemodialysis for acute kidney injury?

Hemodialysis Prescription for Acute Kidney Injury

For patients initiating hemodialysis for AKI, prescribe a minimum 3-hour session duration, use standard dialysate composition (bicarbonate 35-40 mEq/L, calcium 2.5-3.0 mEq/L, potassium 2-3 mEq/L, sodium 140 mEq/L), and calculate ultrafiltration volume based on fluid overload while targeting rates below 13 mL/kg/h to minimize hemodynamic instability. 1

Treatment Duration

• Prescribe a bare minimum of 3 hours per hemodialysis session for patients with minimal residual kidney function (<2 mL/min) receiving thrice-weekly treatments 1

• Consider extending treatment time beyond 3 hours for patients with:

  • Large interdialytic weight gains 1
  • High required ultrafiltration rates 1
  • Poorly controlled blood pressure 1
  • Difficulty achieving dry weight 1
  • Poor metabolic control (hyperphosphatemia, metabolic acidosis, hyperkalemia) 1

• In AKI patients specifically, shorter high-efficiency dialysis (2 hours at blood flow 400 mL/min) produces fewer intradialytic symptoms compared to longer sessions (4 hours at 200 mL/min), though this must be balanced against ultrafiltration requirements 2

Dialysate Composition

Standard Components:

• Sodium: 140 mEq/L as the baseline concentration 3
• Bicarbonate: 35-40 mEq/L for acid-base correction 3
• Calcium: 2.5-3.0 mEq/L (individualize based on serum calcium and phosphate) 3
• Potassium: 2-3 mEq/L (adjust based on serum potassium; use 3-4 mEq/L if patient is normokalemic) 3
• Magnesium: 0.5-1.0 mEq/L 3

Sodium Modulation for Hemodynamic Stability:

• For hemodynamically unstable AKI patients, use variable sodium dialysate starting at 160 mEq/L for the first half of treatment, then decreasing to 140 mEq/L for the second half 4, 5
• This approach significantly reduces the need for vasopressor intervention (16% vs 48.4%, p<0.001) and improves hemodynamic stability 4
• Variable sodium dialysate creates a transcellular fluid shift from intracellular to extracellular compartments, improving plasma refilling and blood volume stability 5

Ultrafiltration Calculation and Rate

Volume Determination:

• Calculate total ultrafiltration volume based on:
  • Clinical assessment of fluid overload (edema, pulmonary congestion) 1
  • Interdialytic weight gain 1
  • Target dry weight achievement 1

Rate Limitations:

• Target ultrafiltration rates below 13 mL/kg/h (weight-scaled) to minimize complications 6
• Recent data from AKI patients shows median ultrafiltration rates of 5.61 mL/kg/h during intermittent hemodialysis, which is substantially higher than the 1.75 mL/kg/h threshold associated with adverse outcomes in continuous renal replacement therapy 6
• Prescribe ultrafiltration rates that balance euvolemia achievement with hemodynamic stability, accepting that some fluid may need to be removed over multiple sessions rather than aggressively in a single treatment 1

Ultrafiltration Profiling:

• For hemodynamically unstable patients, use variable ultrafiltration profiling: remove 50% of total ultrafiltration volume during the first third of treatment time, and 50% over the remaining two-thirds 4
• This profiling approach, combined with variable sodium dialysate, produces superior hemodynamic stability compared to constant ultrafiltration rates 4
• Variable ultrafiltration reduces relative blood volume changes despite achieving greater total fluid removal 4

Critical Pitfalls to Avoid

• Avoid excessive ultrafiltration rates that compromise hemodynamic stability and potentially worsen renal recovery through repeated hypotensive insults 4
• Do not use fixed protocols without considering hemodynamic status: AKI patients in intensive care settings require more aggressive hemodynamic monitoring and intervention compared to chronic dialysis patients 4
• Recognize that high urea removal rates correlate with increased intradialytic symptoms (p=0.0044), so balance solute clearance goals against patient tolerance 2
• Monitor for complications of variable sodium dialysate, including potential sodium loading and thirst, though these are generally outweighed by hemodynamic benefits in unstable patients 5

Monitoring During Treatment

• Reduce dietary sodium intake in conjunction with adequate sodium/water removal to manage hypertension, hypervolemia, and left ventricular hypertrophy 1
• Blood pressure changes are primarily influenced by ultrafiltration volume (p<0.001), so anticipate hypotension risk when large volume removal is required 2
• Symptoms between dialysis sessions are determined by urea removal and ultrafiltration volume rather than membrane characteristics 2